Literature DB >> 32620593

Refusal of viral testing during the SARS-CoV-2 pandemic.

John H McDermott1, William G Newman2.   

Abstract

Widespread testing for the respiratory syndrome coronavirus-2 (SARS-CoV-2) will represent an important part of any strategy designed to safely reopen societies from lockdown. Healthcare settings have the potential to become reservoirs of infectivity, and therefore many hospital trusts are beginning to carry out routine screening of staff and patients. This could promote the effective cohorting of patients and reduce the rate of nosocomial infection. However, for various reasons, some individuals may refuse this testing. Here we highlight this as an emergent ethicolegal issue which we expect to become increasingly relevant as testing becomes ubiquitous. We explore this position from an ethical and legal perspective, determining whether refusal of testing is acceptable under UK law. Individual patients refusing testing could undermine a hospital's testing strategy; therefore clinicians and policy makers must prospectively determine the best course of action if this were to occur. © Royal College of Physicians 2020. All rights reserved.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; Testing; ethics

Mesh:

Year:  2020        PMID: 32620593      PMCID: PMC7539710          DOI: 10.7861/clinmed.2020-0388

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  6 in total

1.  The role of informed consent in tuberculosis testing and screening.

Authors:  Carl H Coleman; Michael J Selgelid; Andreas Reis; Lee B Reichman; Ernesto Jaramillo
Journal:  Eur Respir J       Date:  2012-05       Impact factor: 16.671

2.  Testing for HIV: concise guidance.

Authors:  Adrian Palfreeman; Martin Fisher; Ed Ong; James Wardrope; Ewen Stewart; Enrique Castro-Sanchez; Tim Peto; Karen Rogstad; Julian Sheather; Brian Gazzard; Deenan Pillay; Jane O'Brien; Valerie Delpech; Ruth Lowbury; Russell Fleet; Yusuf Azad; Hermione Lyall; James Hardie; Godwin Adegbite; Guy Rooney; Richard Whitehead
Journal:  Clin Med (Lond)       Date:  2009-10       Impact factor: 2.659

3.  Testing without consent.

Authors:  Paul Robert Grime
Journal:  Occup Med (Lond)       Date:  2013-03       Impact factor: 1.611

Review 4.  Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis.

Authors:  Rebecca F Baggaley; Marie-Claude Boily; Richard G White; Michel Alary
Journal:  AIDS       Date:  2006-04-04       Impact factor: 4.177

5.  COVID-19: the case for health-care worker screening to prevent hospital transmission.

Authors:  James R M Black; Chris Bailey; Joanna Przewrocka; Krijn K Dijkstra; Charles Swanton
Journal:  Lancet       Date:  2020-04-16       Impact factor: 79.321

Review 6.  Clinical management and infection control of SARS: lessons learned.

Authors:  Vincent C C Cheng; Jasper F W Chan; Kelvin K W To; K Y Yuen
Journal:  Antiviral Res       Date:  2013-08-28       Impact factor: 5.970

  6 in total
  6 in total

1.  Community Mitigation of COVID-19 and Portrayal of Testing on TikTok: Descriptive Study.

Authors:  Corey H Basch; Jan Mohlman; Joseph Fera; Hao Tang; Alessia Pellicane; Charles E Basch
Journal:  JMIR Public Health Surveill       Date:  2021-06-10

Review 2.  Critical Ethics: How to Balance Patient Autonomy With Fairness When Patients Refuse Coronavirus Disease 2019 Testing.

Authors:  Piroska K Kopar; Jessica B Kramer; Douglas E Brown; Grant V Bochicchio
Journal:  Crit Care Explor       Date:  2021-01-22

3.  Public Attitudes and Factors of COVID-19 Testing Hesitancy in the United Kingdom and China: Comparative Infodemiology Study.

Authors:  Leesa Lin; Yi Song; Qian Wang; Jialu Pu; Fiona Yueqian Sun; Yixuan Zhang; Xinyu Zhou; Heidi J Larson; Zhiyuan Hou
Journal:  JMIR Infodemiology       Date:  2021-08-27

4.  Low case numbers enable long-term stable pandemic control without lockdowns.

Authors:  Sebastian Contreras; Jonas Dehning; Sebastian B Mohr; Simon Bauer; F Paul Spitzner; Viola Priesemann
Journal:  Sci Adv       Date:  2021-10-08       Impact factor: 14.136

5.  Feasibility and utility of facemask sampling in the detection of SARS-CoV-2 during an ongoing pandemic.

Authors:  Dorothy Hui Lin Ng; Mei Yi Sim; Hong Hong Huang; Jean Xiang Ying Sim; Jenny Guek Hong Low; Jay Kheng Sit Lim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-07-05       Impact factor: 3.267

6.  The impact of control and mitigation strategies during the second wave of coronavirus infections in Spain and Italy.

Authors:  Marco De Nadai; Kristof Roomp; Bruno Lepri; Nuria Oliver
Journal:  Sci Rep       Date:  2022-01-20       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.